NEW YORK (GenomeWeb) – Japanese stem cell products company Reprocell said today that it has purchased 3D cell culture firm Reinnervate and US genomics services firm BioServe.
NEW YORK (GenomeWeb News) – DNA Genotek and BioServe Biotechnologies announced today their participation in a genomic study into craniofacial anomalies in Ethiopia.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
BioServe touts the repository as the "the largest resource of high-quality biosamples for the life science industry" and claims that researchers can access it to garner biosamples from "most any major diseases."
The firm has started the BioServe Network with partners including Fox Chase, Windber, UMass, and the Fairbanks Institute for Healthy Communities.
Seegene's SeePrep and SeeCycler instruments; Bioo's ExoMir kit for fractionation and RNA extraction; BioServe PCR-based tests for detecting GMOs; Chemagen's Chemagic total RNA kit.
BioServe will supplement its clinical-grade biospecimens in its Global BioRepository with biosamples from the Windber Research Institute's Tissue Bank.
SpectraCell offering apoE genotyping; BioServe to provide genetic testing services for NGC Medical
The US genomics services firm will serve as the testing lab for NGC's nutrigenomics services.
Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.
Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.
In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.
An opinion piece at Bloomberg discusses China's stance on genomic research.